Significant body weight reduction with cagrilintide-semaglutide therapy
1. In this randomized controlled trial, the combination cagrilintide-semaglutide (CagriSema) resulted in significantly greater body weight reduction compared to either ...
1. In this randomized controlled trial, the combination cagrilintide-semaglutide (CagriSema) resulted in significantly greater body weight reduction compared to either ...
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. By week 26, cagrilintide resulted in significantly increased weight reduction compared to liraglutide and placebo. 2. Gastrointestinal adverse events, ...
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.